The pathologist's view point. Part II --aggressive lymphomas.

A clinician’s guide to the updated REAL/WHO classification of non-Hodgkin’s lymphoma: part II (aggressive lymphomas)

Neoatherosclerosis From a Pathologist's Point of View.

Expression of Apoptosis Related and Proliferative Proteins in Malignant Lympho-Proliferative Disorders

Background & objective: The current study aimed to perform an immunohistochemical analysis of patterns of apoptotic and cell proliferative related protein expression in different histological grades and immune phenotypes of malignant lymphomas and other lymphoproliferative disorders Methods:This observational study was carried o...

A Pathologist's Survey of Superficial Tumors Removed in a Casualty Department *Originally written for the Report of the South Western Regional Cancer Records Bureau and reproduced with permission of the Director.This material came from the Casualty Department of the Bristol Royal Infirmary.

or surgical illness to the patient who wishes to have a minor cutaneous blemish removed for cosmetic reasons. It is especially the people in the last category and those with less trivial but apparently minor superficial lesions who provide a wealth of varied problems for the diagnostic histology department. Fortunately it is the custom t0 send all such tissue for examination. From the pathologi...

Can we cure indolent lymphomas?

The current consensus is that indolent lymphomas are incurable disorders. There are some indications that these malignancies are potentially curable. Indeed, not all indolent lymphomas are currently incurable. For example, patients with Ann Arbor stage I-II indolent lymphomas can experience long-term disease-free survival and probable cure. Also, from the available literature data, it seems tha...